Multidrug resistance in non-small-cell lung cancer

Annals of Oncology

Volumn 10, Issue SUPPL. 5, 1999, Pages

  Scagliotti, G V ^a   Novelle, S ^a   Selvaggi, G ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Lung resistance related protein; Multidrug resistance; Multidrug resistance protein; Non small cell lung cancer; P glycoprotein; Topoisomerases

Indexed keywords

6 O ALKYLGUANINE DNA ALKYLTRANSFERASE; ANTHRACYCLINE ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; DIHYDROFOLATE REDUCTASE; DNA TOPOISOMERASE (ATP HYDROLYSING); ETOPOSIDE; GLYCOPROTEIN P; HEAT SHOCK PROTEIN; METALLOTHIONEIN; MULTIDRUG RESISTANCE PROTEIN; TENIPOSIDE; THYMIDYLATE SYNTHASE;

CELL PROLIFERATION; CONFERENCE PAPER; LUNG NON SMALL CELL CANCER; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT FAILURE;

EID: 0032692162     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/10.suppl_5.S83     Document Type: Conference Paper

References (20)

1. Sckinkel AH, Borst P. Multidrug resistance mediated by P-glycoprotein. Semin Cancer Biol 1991; 2: 213-36.
2. Thiebaut F, Tsuruo T, Hamada H et al. Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P-170: Evidence for localization in brain capillaries and cross-reactivity on one antibody with a muscle protein. J Hystochem Cytochem 1989; 37: 159.
3. Goldstein LJ, Galski H, Fojo A et al. Expression of multidrug resistance gene in human cancers. J Natl Cancer Inst 1989; 81: 116-24.
4. Scagliotti GV, Michelotto P, Kalikatzaros G et al. Detection of multidrug resistance associated P-170 glycoprotein in previously untreated non-small-cell lung cancer. Anticancer Res 1991; 11: 2207-10.
5. Shin HJC, Lee JS, Hong WK, Shin DM. Study of multidrug resistance (mdrl) gene in non-small-cell lung cancer. Anticancer Res 1992; 12: 367-70.
6. Oka M, Fukuda M, Sakamoto A et al. The clinical role of MDR1 gene expression in human lung cancer. Anticancer Res 1997; 17 (1B): 721-4.
7. Millward MJ, Cantwell BMJ, Munro NC et al. Oral verapamil with chemotherapy for advanced non-small-cell lung cancer: A randomized study. Br J Cancer 1993; 67: 1031-5.
8. Milroy R. A randomized clinical study of verapamil in addition to combination chemotherapy in small-cell lung cancer. Br J Cancer 1993; 68: 813-8.
9. Grant CE, Valdimarsson G, Hipfner DR et al. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res 1994; 54: 357-61.
10. Narasaki F, Oka M, Fukuda M et al. Multidrug resistance-associated protein gene expression and drug sensistivity in human lung cancer cells. Anticancer Res 1997; 17 (5A): 3493-7.
11. Giaccone G, van Ark-Otte J. Rubio GJ et al. MRP is frequently expressed in human lung cancer cell lines, in non-small-cell lung cancer and in normal lung. Int J Cancer 1996; 66: 760-7.
12. Ota E, Abe Y, Oshika Y et al. Expression of the multidrug resistance-associated protein (MRP) gene in non-small-cell lung cancer. Br J Cancer 1995; 72: 550-4.
13. Drake PH, Hofmann GA, Bartus HF et al. Biochemistry 1989; 28: 8154-60.
14. Giaccone G, van Ark-Otte J. Scagliotti G et al. Differential expression of DNA topoisomerases in non-small-cell lung cancer and normal tissue. Biochim Biophys Acta 1995; 1264: 337-46.
15. Kasahara K, Fujiwara Y, Sugimoto Y et al. Determinants of response to the DNA topoisomerase II inhibitors doxorubicin and etoposide in human lung cancer cell lines. J Natl Cancer Inst 1992; 84: 113.
16. Giaccone G, Gazdar AF, Beck H et al. Multidrug sensitivity phanotype of human lung cancer cells associated with topoisomerase II expression. Cancer Res 1992; 52: 1666.
17. Scheffer GL, Wijngaard PLJ, Flens MJ et al. The drug resistance related protein LRP ia a major vault protein. Nature Med 1995; 1: 578.
18. Izquierdo MA, Scheffer GL, Flens MJ et al. Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumors. Am J Pathol 1996; 148: 877-87.
19. Dingermans AM, van Ark-Otte J, van der Valk P et al. Expression of the human major vault protein LRP in human lung cancer samples and normal lung tissues. Ann Oncol 1996; 7: 625-30.
20. Volm M, Mattern J, Koomagi R. Expression of lung resistance-related protein (LRP) in non-small-cell lung carcinomas of smokers and its predictive value for doxorubicin resistance. Anticancer Drugs 1997; 8: 931-6.